2017-03-16,Biotech Premarket Movers: Seres, PTC, Inovio
2017-03-16,PTC Therapeutics Announces Agreement To Acquire Emflaza™ For The Treatment Of Duchenne Muscular Dystrophy In U.S.
2017-03-13,PTC Therapeutics Announces Timing Change For Fourth Quarter And Year End 2016 Financial Results
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-03-08,Could These 9 Drugs Gain FDA Approval in the Age of Trump?
2017-03-08,The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
2017-03-06,Biotech Premarket Movers: PTC, Teligent, Minerva
2017-03-06,PTC Therapeutics Announces FDA Acknowledgment Of New Drug Application Filing For Translarna™ For The Treatment Of Nonsense Mutation Duchenne Muscular Dystrophy
2017-03-02,Relative Strength Alert For PTC Therapeutics
2017-03-02,Biotech Premarket Movers: Aurinia, Puma, PTC, Juno
2017-03-02,PTC Therapeutics Suffers Cystic Fibrosis Setback, Dimming Hopes for Any U.S. Approvals
2017-03-02,PTC Therapeutics Announces Results From Pivotal Phase 3 Clinical Trial Of Ataluren In Patients Living With Nonsense Mutation Cystic Fibrosis
2017-02-21,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2017-02-10,Noteworthy Friday Option Activity: PTCT, UVV, SREV
2017-02-08,PTC Therapeutics Announces Third Annual STRIVE Grant Award Program For Duchenne Muscular Dystrophy
2017-01-10,Sarepta Opens Up About Duchenne Drug Launch, Allays Investors' Worst Fears
2017-01-10,PTCT Crosses Above Average Analyst Target
2017-01-09,European Commission Ratifies Positive CHMP Opinion For The Renewal Of Translarna™ Marketing Authorization For The Treatment Of Nonsense Mutation Duchenne Muscular Dystrophy
2017-01-09,PTC Therapeutics Provides Corporate Update And Outlines 2017 Strategic Priorities To Maximize The Global Value Of Translarna™ And Advance Its Innovative Pipeline
2017-01-06,RG7916 Granted Orphan Drug Designation In The U.S. For The Treatment Of Spinal Muscular Atrophy
2017-01-05,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2017-01-05,Notable Thursday Option Activity: PTCT, HAIN, MRTX
2017-01-05,PTC Therapeutics Announces Initiation Of FIREFISH Study In Infant (Type I) SMA Patients
2016-12-22,Commit To Purchase PTC Therapeutics At $8, Earn 23.8% Using Options
2016-12-16,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2016-12-08,PTC Therapeutics Receives France's 2016 Prix Galien For Translarna™
2016-11-18,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2016-11-11,PTC Therapeutics Duchenne Drug Wins Extended European Approval
2016-11-11,CHMP Recommends Renewal Of Translarna's™ Marketing Authorization For Nonsense Mutation Duchenne Muscular Dystrophy Based On Continued Positive Benefit-Risk Assessment
2016-10-24,Bullish and Bearish Reversals for the Week
2016-10-20,Spinal Muscular Atrophy Program Advances Into Phase 2 Clinical Studies In SMA Patients With RG7916
2016-10-19,RSI Alert: PTC Therapeutics (PTCT) Now Oversold
2016-10-17,PTC Therapeutics Getting Cold Shoulder From Regulators on Duchenne Drug Appeal
2016-10-17,PTC Therapeutics Provides Regulatory Update On Translarna™ (ataluren) For Nonsense Mutation Duchenne Muscular Dystrophy
2016-10-06,PTC Therapeutics Announces New Analyses That Support The Potential Benefit Of Ataluren In Preserving Lung Function In Non-Ambulatory Nonsense Mutation Duchenne Muscular Dystrophy Patients
2016-10-04,New Research Validates Translarna's™ (ataluren) Mechanism Of Action To Promote Readthrough Of Nonsense Mutations And Produce Full-length Functional Protein
2016-09-20,Commit To Purchase PTC Therapeutics At $5, Earn 22% Using Options
2016-09-12,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2016-09-07,PTC Therapeutics Recognizes World Duchenne Awareness Day by Announcing Winners of Global Duchenne Muscular Dystrophy Patient Group Awards and Expanding Disease State Awareness Website
2016-08-16,10 Best-Performing Stocks This Earnings Season
2016-08-08,Today's Perilous Reversal Stock: PTC Therapeutics (PTCT)
2016-08-05,Strong On High Volume: PTC Therapeutics (PTCT)
2016-07-25,PTC Therapeutics Duchenne Drug Stuck on Conditional Approval Status in Europe
2016-07-25,PTC Therapeutics Provides Regulatory Update On Translarna™ (ataluren)
2016-07-20,Strong On High Relative Volume: PTC Therapeutics (PTCT)
2016-07-07,NHS England Enables Access To Translarna™ ¿ (ataluren) For Patients With Nonsense Mutation Duchenne Muscular Dystrophy
2016-06-21,Commit To Purchase PTC Therapeutics At $5, Earn 30% Using Options
2016-06-13,PTC Therapeutics Appoints Dawn Svoronos To Board Of Directors
2016-06-10,New Analyses From Phase 3 Study 009 Of Translarna™ (ataluren) In Patients With Cystic Fibrosis Presented At 39th European Cystic Fibrosis Conference
2016-06-10,Biotech Stock Mailbag: Sarepta! Always More Sarepta. And Gilead, Too
2016-06-06,PTC Therapeutics (PTCT) Marked As A Dead Cat Bounce Stock
2016-05-25,PTC Therapeutics (PTCT) Weak On High Volume
2016-05-02,PTC Therapeutics (PTCT) Marked As A Dead Cat Bounce Stock
2016-05-02,DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders Of PTC Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 2, 2016 - PTCT
2016-04-29,GPM Reminds Investors Of The May 2 Deadline In The Class Action Lawsuit Against PTC Therapeutics, Inc. And Encourages Investors To Contact The Firm
2016-04-26,PTC Therapeutics Appoints Dr. Tuyen Ong As Chief Medical Officer
2016-04-22,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2016-04-22,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of PTC Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 2, 2016 - PTCT
2016-04-20,EXPANDED CLASS PERIOD: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against PTC Therapeutics, Inc. And Encourages Investors With Losses To Contact The Firm
2016-04-19,INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Involving PTC Therapeutics, Inc. And A Lead Plaintiff Deadline Of May 2, 2016 - PTCT
2016-04-19,Today's Dead Cat Bounce Stock Is PTC Therapeutics (PTCT)
2016-04-18,Perilous Reversal Stock: PTC Therapeutics (PTCT)
2016-04-15,The Former Attorney General Of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors Of Lead Plaintiff Deadline In Class Action Lawsuit Against PTC Therapeutics, Inc. - PTCT
2016-04-15,SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Class Action Involving PTC Therapeutics, Inc. And A Lead Plaintiff Deadline Of May 2, 2016 - PTCT
2016-04-15,Why PTC Therapeutics (PTCT) Stock Is Spiking Today
2016-04-15,NICE Recommends Translarna™ (ataluren) For The Treatment Of Patients With Nonsense Mutation Duchenne Muscular Dystrophy In England
2016-04-14,SHAREHOLDER ALERT- Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against PTC Therapeutics Inc. (PTCT) And Lead Plaintiff Deadline: May 2, 2016
2016-04-12,INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of PTC Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of May 2, 2016
2016-04-11,Wolf Popper LLP Reminds Shareholders Of The Class Action Lawsuit Against PTC Therapeutics, Inc.
2016-04-08,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In PTC Therapeutics, Inc. Of Class Action Lawsuit And Upcoming Deadline - PTCT
2016-04-08,INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Class Action Involving PTC Therapeutics, Inc. And A Lead Plaintiff Deadline Of May 2, 2016 - PTCT
2016-04-02,Looking for Sunshine in Biotech's Gloomy First-Quarter Performance
2016-04-01,The Former Attorney General Of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors Of Lead Plaintiff Deadline In Class Action Lawsuit Against PTC Therapeutics, Inc.
2016-03-24,STOCK NOTICE: Rosen Law Firm Reminds PTC Therapeutics, Inc. Investors Of Important Deadline In Class Action
2016-03-24,SHAREHOLDER ALERT: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against PTC Therapeutics, Inc. And Encourages Investors With Losses To Contact The Firm
2016-03-23,PTC Therapeutics Announces Workforce Reduction As Part Of Operating Expense Management Plan
2016-03-22,First Week Of May 20th Options Trading For PTC Therapeutics (PTCT)
2016-03-21,Shareholder Class Action Filed Against PTC Therapeutics, Inc. - PTCT
2016-03-17,5 Stocks Under $10 Set to Soar
2016-03-14,PTC Therapeutics (PTCT) In A Perilous Reversal
2016-03-14,PTC Therapeutics Provides Update On Health Canada Review Of Translarna™ (ataluren) For The Treatment Of Duchenne Muscular Dystrophy
2016-03-14,PTC Therapeutics Announces Presentation Of Results From Phase 3 ACT DMD Clinical Trial Of Translarna™ (ataluren) In Patients With Duchenne Muscular Dystrophy At 5th International Congress Of Myology
2016-03-14,7 Breakout Stocks Spiking on Big Volume
2016-03-11,Law Offices Of Marc S. Henzel Commences Investigation Of Companies For Violations Of The Federal Securities Laws
2016-03-09,EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against PTC Therapeutics, Inc.
2016-03-02,Today's Dead Cat Bounce Stock Is PTC Therapeutics (PTCT)
2016-03-02,PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2016-03-01,IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Investigation Of PTC Therapeutics, Inc. And Urges Investors With Losses To Contact The Firm
2016-03-01,PTC Therapeutics (PTCT) Stock Price Cut at Credit Suisse
2016-02-26,Germany Slaps PTC Therapeutics With Big Drug Price Cut
2016-02-26,PTC Therapeutics Provides Update On German Pricing And Reimbursement Process For Translarna™ (ataluren)
2016-02-26,Perilous Reversal Watch: PTC Therapeutics (PTCT)
2016-02-25,PTC Therapeutics (PTCT) Stock Price Target Cut at Oppenheimer
2016-02-24,Here&rsquo;s Why PTC Therapeutics (PTCT) Stock is Down Today
2016-02-24,PTC Therapeutics (PTCT) Is Today's Dead Cat Bounce Stock
2016-02-24,PTC Therapeutics (PTCT) Stock Upgraded at Jefferies
2016-02-24,Investigation Of PTC Therapeutics By Block & Leviton For Possible Violations Of Federal Securities Laws
2016-02-23,PTC INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates PTC Therapeutics, Inc. For Possible Securities Fraud
2016-02-23,EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PTC Therapeutics, Inc. - PTCT
2016-02-23,Noteworthy Tuesday Option Activity: PTCT, HSNI, CRAI
2016-02-23,GPM Announces Investigation On Behalf Of PTC Therapeutics, Inc. Investors
2016-02-23,SHAREHOLDER ALERT: Scott + Scott, LLP Investigating PTC Therapeutics (PTCT) For Possible Securities Fraud
2016-02-23,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud Violations By The Board Of PTC Therapeutics, Inc.
2016-02-23,Relative Strength Alert For PTC Therapeutics
2016-02-23,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of PTC Therapeutics Inc. (PTCT)
2016-02-23,PTC Therapeutics (PTCT) Stock Plunges After Receiving FDA 'Refuse to File' Letter
2016-02-23,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of PTC Therapeutics, Inc. - PTCT
2016-02-23,PTC Therapeutics (PTCT) Trading With Heavy Volume Before Market Open
2016-02-23,PTC Receives Refuse To File Letter From FDA For Translarna™ (ataluren)
2016-02-12,PTC Therapeutics Announces Second Annual STRIVE Grant Award Program For Duchenne Muscular Dystrophy
2016-02-11,Short Interest In PTC Therapeutics Increases 19%
2016-01-19,PTC Therapeutics (PTCT) Strong On High Relative Volume Today
2016-01-15,PTC Therapeutics (PTCT) Showing Signs Of Perilous Reversal Today
2016-01-11,PTC Therapeutics Enters Oversold Territory (PTCT)
2016-01-11,PTC Therapeutics Outlines Business Priorities For The Development And Commercialization Of Translarna™ And Progress Of The Company Pipeline
2016-01-08,PTC Completes Rolling NDA Submission To FDA And Submits Phase 3 ACT DMD Clinical Trial Results To EMA For Translarna™ (ataluren) For Treatment Of Nonsense Mutation Duchenne Muscular Dystrophy
2016-01-07,Spinal Muscular Atrophy Program Advances With Additional Product Candidate Entering Clinical Development
2016-01-06,PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2016-01-05,These 5 Health Care Stocks Are Ready for Breakout Moves: Must-See Charts
2015-12-16,Notable Wednesday Option Activity: PTCT, FMI, ENPH
2015-12-16,PTC Therapeutics (PTCT) Marked As A Barbarian At The Gate
2015-12-09,PTC Therapeutics And Massachusetts General Hospital Collaborate On Rare Disease Research
2015-12-04,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2015-11-24,PTC Therapeutics (PTCT) Is Today's Perilous Reversal Stock
2015-11-20,PTC Therapeutics (PTCT) Showing Signs Of A Dead Cat Bounce Today
2015-11-20,Before the Move: Watch BioMarin Into FDA Advisory Committee
2015-11-19,These Biotech Stocks Could Move on BioMarin's Duchenne Drug FDA Panel
2015-11-19,PTC Completes Enrollment Of Phase 3 Clinical Trial Of Translarna™ For Patients With Cystic Fibrosis
2015-11-18,Strong On High Volume: PTC Therapeutics (PTCT)
2015-11-03,PTC Therapeutics (PTCT) Stock: Weak On High Volume Today
2015-10-29,PTC Therapeutics Announces Launch Of STRIVE Grant Award Program For Cystic Fibrosis
2015-10-27,PTC Therapeutics To Host Conference Call To Discuss Third Quarter 2015 Financial Results
2015-10-27,Today's Dead Cat Bounce Stock Is PTC Therapeutics (PTCT)
2015-10-21,First Week Of June 2016 Options Trading For PTC Therapeutics (PTCT)
2015-10-19,Perilous Reversal Stock: PTC Therapeutics (PTCT)
2015-10-16,Today's Pre-Market Mover With Heavy Volume: PTC Therapeutics (PTCT)
2015-10-15,PTC Announces Results From Phase 3 ACT DMD Clinical Trial Of Translarna™ (ataluren) In Patients With Duchenne Muscular Dystrophy
2015-10-05,Perilous Reversal Stock: PTC Therapeutics (PTCT)
2015-10-04,Phase 2 Data From Spinal Muscular Atrophy Program To Be Presented At The 20th International Annual Congress Of The World Muscle Society
2015-10-02,PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2015-09-30,PTC Therapeutics Submits European Application For Translarna™ For Cystic Fibrosis
2015-09-29,Oversold Conditions For PTC Therapeutics (PTCT)
2015-09-28,Short Interest In PTC Therapeutics Jumps 10.6%
2015-09-25,Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird
2015-09-23,PTC Therapeutics (PTCT) Is Weak On High Volume Today
2015-09-21,Perilous Reversal Stock: PTC Therapeutics (PTCT)
2015-09-18,'Mad Money' Lightning Round: Eaton Is a Buy, Buy, Buy
2015-09-17,Jim Cramer's 'Mad Money' Recap: The Fed Is Making All the Right Moves
2015-09-17,PTC Therapeutics (PTCT) Marked As A Dead Cat Bounce Stock
2015-08-28,First Week of October 16th Options Trading For PTC Therapeutics (PTCT)
2015-08-27,Predicting the Outcome of the BioMarin and Sarepta FDA Drug Reviews
2015-08-25,PTC Therapeutics (PTCT) Is Strong On High Volume Today
2015-08-21,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2015-08-19,‘Female Viagra’ approval seen as positive for Sarepta, BioMarin
2015-08-18,Perilous Reversal Stock: PTC Therapeutics (PTCT)
2015-08-14,PTC Therapeutics Announces Closing Of $150 Million Of Convertible Senior Notes
2015-08-11,Today's Pre-Market Mover With Heavy Volume: PTC Therapeutics (PTCT)
2015-08-11,PTC Therapeutics Announces Pricing Of $125 Million Of Convertible Senior Notes
2015-08-10,PTC Therapeutics Announces Intention To Offer Convertible Senior Notes
2015-07-22,Today's Dead Cat Bounce Stock: PTC Therapeutics (PTCT)
2015-07-22,Interesting PTCT Put And Call Options For March 2016
2015-07-16,PTC Therapeutics To Host Conference Call To Discuss Second Quarter 2015 Financial Results
2015-07-15,Strong On High Relative Volume: PTC Therapeutics (PTCT)
2015-07-15,Analysts' Actions -- CSX, LinkedIn, Micron and More
2015-06-23,PTC Therapeutics' CEO Stuart W. Peltz, Ph.D. Recipient Of The 2015 NJBiz Innovation Hero Award
2015-06-22,Insider Trading Alert - PTCT, HES And HTGC Traded By Insiders
2015-06-17,Trade-Ideas: PTC Therapeutics (PTCT) Is Today's "Dead Cat Bounce" Stock
2015-05-27,November 20th Options Now Available For PTC Therapeutics (PTCT)
2015-05-21,German Federal Joint Committee Issues Positive Medical Benefit Rating For Translarna™ In Patients With Nonsense Mutation Duchenne Muscular Dystrophy
2015-05-19,First Week Of July 17th Options Trading For PTC Therapeutics (PTCT)
2015-05-15,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2015-05-11,PTC Therapeutics Launches STRIVE Grant Award Program
2015-05-06,PTC Therapeutics (PTCT) Marked As A Dead Cat Bounce Stock
2015-04-28,PTC Therapeutics' Cancer Stem Cell Program Targeting BMI1 Enters Phase 1
2015-04-23,Santhera -- A Duchenne Drug With Positive Study Results That Few Know About
2015-04-20,PTC Therapeutics To Host Conference Call To Discuss First Quarter 2015 Financial Results
2015-04-20,Phase 1 Data From Spinal Muscular Atrophy Program To Be Presented At The 2015 American Academy Of Neurology Annual Meeting
2015-04-10,PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2015-04-09,Deutsche Compares PTC Therapeutics To Vertex, Boosts Target By $40
2015-04-08,PTC Therapeutics Names Eric Pauwels SVP & General Manager Commercial Operations, Americas
